We created standardized aseptic filling technologies for today's complex therapies — not yesterday's status quo.
Cytiva's robotic Aseptic Filling Workcells enable flexible manufacturing and bring drug products to patients faster. We don't know what else to say except: you're welcome.
We are delighted to be returning to INTERPHEX in New York this May 24th-26th. Join us at booth #2933 to see how Cytiva's gloveless, robotic isolators can reduce risk in your aseptic filling operations and advance your therapies from idea to injection.
How have your peers solved challenges that you face in drug product manufacturing?
Find out by answering three simple questions. We'll build a customized white paper—on the spot—that you can download and share.
More automation or more flexibility? How about both. Greater precision or faster time to market? You bet.
Biopharmaceutical manufacturing experts created Vanrx to make a new type of aseptic filling machine that is up to the challenge of complex new therapeutics. Companies including Roche / Genentech, Moderna and FUJIFILM Diosynth trust Vanrx as a key partner in making commercial and clinical drug products.
See more customer stories“If you’re not using the [Vanrx] Microcell technology, you’re going to fall behind in the market.”
Greg Merril
CEO, Adaptive Phage Therapeutics
You can be part of a rapidly growing company serving in the dynamic biopharmaceutical industry. Vanrx relies on all of its team members—engineering, manufacturing, technical services and sales—working together to serve our world-class customer base.
We are a science-driven, Vancouver-based company where bureaucracy and politics are discouraged. You can focus on doing amazing work with other talented people.
